Acelrx Pharmaceuticals reported $24.54M in Current Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Acelrx Pharmaceuticals ACRX:US USD 24.54M 7.46M
Baxter International BAX:US USD 8.01B 201M
Becton, Dickinson and BDX:US USD 8.18B 34M
Cara Therapeutics CARA:US USD 168.91M 17.87M
Heron Therapeutics HRTX:US USD 205.44M 18.37M
Intra Cellular Therapies ITCI:US USD 737.96M 21.8M
Pain Therapeutics PTIE:US USD 211.23M 27.95M
Smiths SMIN:LN GBP 2.26B 155M
Teva Pharmaceutical TEVA:IT USD 12.05B 598M
Xeris Pharmaceuticals Inc XERS:US USD 186.82M 37.9M